Erratum: Downregulation of FoxM1 inhibits the viability and invasion of gallbladder carcinoma cells, partially dependent on the induction of cellular senescence (World Journal of Gastroenterology (2014) 20 (9497-9505) DOI: 10.3748/wjg.v20.i28.9497);Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence

World Journal of Gastroenterology

Volumn 20, Issue 28, 2014, Pages 9497-9505

  Tao, Jie ^a   Xu, Xin Sen ^a   Song, Yan Zhou ^b   Qu, Kai ^a   Wu, Qi Fei ^a   Wang, Rui Tao ^a   Meng, Fan Di ^a   Wei, Ji Chao ^a   Dong, Shun Bin ^a   Zhang, Yue Lang ^a   Tai, Min Hui ^c   Dong, Ya Feng ^c   Wang, Lin ^a   Liu, Chang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b First People's Hospital of Lianyungang   (China)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Forkhead box M1; Gallbladder carcinoma; Invasion; Senescence; Viability

Indexed keywords

BETA GALACTOSIDASE; FORK HEAD BOX M1; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; MATRIGEL; MESSENGER RNA; PUROMYCIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN;

ARTICLE; CARCINOMA CELL LINE; CELL AGING; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; GALLBLADDER CARCINOMA; HUMAN; HUMAN CELL; MTT ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADENOVIRIDAE; CARCINOMA; CELL MOTION; CELL SURVIVAL; GALLBLADDER TUMOR; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; TUMOR INVASION;

ADENOVIRIDAE; CARCINOMA; CELL AGING; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84908876817     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v27.i26.4241     Document Type: Erratum

References (26)

1. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008; 10: 77-82 [PMID: 18773060 DOI: 10.1080/13651820801992641]
2. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167-176 [PMID: 12623362]
3. Zhu AX, Hezel AF. Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities. Hepatology 2011; 53: 695-704 [PMID: 21274890 DOI: 10.1002/hep.24145]
4. Marino D, Leone F, Cavalloni G, Cagnazzo C, Aglietta M. Biliary tract carcinomas: from chemotherapy to targeted therapy. Crit Rev Oncol Hematol 2013; 85: 136-148 [PMID: 22809696 DOI: 10.1016/j.critrevonc.2012.06.006]
5. Jia J, Li S, Gong W, Ding J, Fang C, Quan Z. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway. Oncol Rep 2011; 25: 195-201 [PMID: 21109977]
6. Li JY, Quan ZW, Zhang Q, Liu JW. The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer 2007; 7: 125 [PMID: 17617924 DOI: 10.1186/1471-2407-7-125]
7. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World J Gastroenterol 2005; 11: 2431-2437 [PMID: 15832413]
8. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Hepatobiliary Pancreat Dis Int 2007; 6: 72-80 [PMID: 17287171]
9. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7: 847-859 [PMID: 17943136 DOI: 10.1038/nrc2223]
10. Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 2007; 1775: 92-102 [PMID: 17014965 DOI: 10.1016/j.bbcan.2006.08.006]
11. Qu K, Xu X, Liu C, Wu Q, Wei J, Meng F, Zhou L, Wang Z, Lei L, Liu P. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer Lett 2013; 331: 105-114 [PMID: 23262037 DOI: 10.1016/j.canlet.2012.12.008]
12. Wu QF, Liu C, Tai MH, Liu D, Lei L, Wang RT, Tian M, Lü Y. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol Sin 2010; 31: 361-366 [PMID: 20154714 DOI: 10.1038/aps.2010.4]
13. Wang R, Song Y, Xu X, Wu Q, Liu C. The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival. Clin Transl Oncol 2013; 15: 626-632 [PMID: 23359173 DOI: 10.1007/s12094-012-0978-9]
14. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62: 1876-1883 [PMID: 11912168]
15. Li X, Qiu W, Liu B, Yao R, Liu S, Yao Y, Liang J. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel. J Transl Med 2013; 11: 204 [PMID: 24004449 DOI: 10.1186/1479-5876-11-204]
16. Xu N, Jia D, Chen W, Wang H, Liu F, Ge H, Zhu X, Song Y, Zhang X, Zhang D, Ge D, Bai C. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis. PLoS One 2013; 8: e59412 [PMID: 23536876 DOI: 10.1371/journal.pone.0059412]
17. Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J Hepatol 2012; 57: 600-612 [PMID: 22613004 DOI: 10.1016/j.jhep.2012.04.020]
18. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367 [PMID: 7568133]
19. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grützmann R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 2004; 6: 744-750 [PMID: 15720800 DOI: 10.1593/neo.04277]
20. Frau M, Feo F, Pascale RM. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J Hepatol 2013; 59: 830-841 [PMID: 23665184 DOI: 10.1016/j.jhep.2013.04.031]
21. Wang Z, Zheng Y, Park HJ, Li J, Carr JR, Chen YJ, Kiefer MM, Kopanja D, Bagchi S, Tyner AL, Raychaudhuri P. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol Cancer Ther 2013; 12: 759-767 [PMID: 23427295 DOI: 10.1158/1535-7163.MCT-12-0903]
22. Yang C, Chen H, Yu L, Shan L, Xie L, Hu J, Chen T, Tan Y. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer. Cancer Gene Ther 2013; 20: 117-124 [PMID: 23306612 DOI: 10.1038/cgt.2012.94]
23. Ly DH, Lockhart DJ, Lerner RA, Schultz PG. Mitotic misregulation and human aging. Science 2000; 287: 2486-2492 [PMID: 10741968]
24. Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, Chick JM, Zhai H, Vidal M, Gygi SP, Braun P, Sicinski P. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 2011; 20: 620-634 [PMID: 22094256 DOI: 10.1016/j.ccr.2011.10.001]
25. Zhang H, Ackermann AM, Gusarova GA, Lowe D, Feng X, Kopsombut UG, Costa RH, Gannon M. The FoxM1 transcription factor is required to maintain pancreatic beta-cell mass. Mol Endocrinol 2006; 20: 1853-1866 [PMID: 16556734 DOI: 10.1210/me.2006-0056]
26. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005; 25: 10875-10894 [PMID: 16314512 DOI: 10.1128/MCB.25.24.10875-10894.2005]